MedTrace Logo

Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis

NCT02264587 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-10-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects and mechanism of mosapride citrate on diabetic gastroparesi.

Conditions

  • Diabetic Gastroparesis

Interventions

DRUG

Mosapride

Mosapride 5mg by mouth ,3 times one day for 1 4days.

DRUG

domperidone

Domperidone 10mg by mouth ,3 times one day for 1 4days.

Sponsors & Collaborators

  • Sumitomo Pharma (Suzhou) Co., Ltd.

    collaborator INDUSTRY

  • Liangzhou Wei

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-09-30
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264587 on ClinicalTrials.gov